- 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
- 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
- 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
- 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们。
- 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
- 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
补阳还五汤在急性心肌梗死血运重建后T波峰末间期及预后影响.doc
补阳还五汤在急性心肌梗死血运重建后T波峰末间期及预后影响
摘要:目的探讨分析补阳还五汤在急性心肌梗死血运重建后T波峰末间期及预后影响。方法以本院2013年4月―2015年4月间,收治的84例急性心肌梗死患者为研究对象,随机分为观察组与对照组各42例,对照组患者予以经皮冠状动脉介入治疗(PCI)或静脉溶栓疗法进行血运重建,观察组患者在对照组基础上,增加服用补阳还五汤,两组患者治疗疗程均为30d,随访观察6个月。结果治疗疗程结束后,观察组患者Tpe及TpeRR、LVESD、LVEDD、LVEF等临床观察指标均明显优于对照组,差异有统计学意义(P0.05)。随访观察结束后,观察组患者严重心血管事件发生率(9.5%)明显低于对照组(19.1%),差异有统计学意义(P0.05)。结论补阳还五汤可以有效缩短急性心肌梗死血运重建后的T波峰末间期,改善心脏结构与功能,降低严重心血管事件发生率,改善临床预后,具有更高的临床应用价值。
关键词:补阳还五汤;急性心肌梗死;血运重建;预后
中图分类号:R256.22文献标志码:A文章编号:1007-2349(2016)07-0024-03
【Abstract】Objective: To study the effect of Buyanghuanwu Decoction on T peak- T end interval and prognosis after the revascularization of acute myocardial infarction. Methods: 84 acute myocardial infarction patients who were treated at our hospital from April, 2013 to April, 2015 were randomly divided into one observation group and one control group, 42 cases per group. The control group was treated with percutaneous coronary intervention (PCI) or intravenous thrombolytic therapy to make revascularization while the observation group was added with Buyanghuanwu Decoction besides basic treatment of the control group. 30 days was a course of treatment and the observation was followed up for 6 months. Results: After the treatment, Tpe, RR, LVESD, LVEDD and LVEF of the treatment group was significantly better than those of the control group, and the difference was statistically significant (P0.05). After the follow-up observation, the severe cardiovascular event rate (9.5%) of the observation group was significantly lower than the rate (19.1%) of the control group, and the difference was statistically significant (P0.05). Conclusion: Buyanghuanwu Decoction can effectively reduce T peak-T end interval of acute myocardial infarction patients after revascularization, improve cardiac structure and function and reduce the incidence of serious cardiovascular events and improve clinical prognosis, with higher clinical value.
【Key words】Buyanghuanwu Decoction, acute myocardial in
文档评论(0)